Vimarsana
Biggest News Aggregation in the World

Simple Dos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Simple Dos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Simple Dos Today - Breaking & Trending Today

Health News | Researchers Suggest Gene Therapy to Treat Neurological Disorders - Vimarsana News

Health News | Researchers Suggest Gene Therapy to Treat Neurological Disorders

Get latest articles and stories on Health at LatestLY. Excessive activity of a limited number of brain cells causes several brain illnesses, including epilepsy. These diseases frequently do not react well to drug treatment, owing to the fact that drug influence the entire brain. A recent study revealed gene therapy to for neurological disorder. Health News | Researchers Suggest Gene Therapy to Treat Neurological Disorders.

Health News | Study Investigates How Immunotherapy Affects COVID-19 Outcomes - Vimarsana News

Health News | Study Investigates How Immunotherapy Affects COVID-19 Outcomes

Get latest articles and stories on Health at LatestLY. A new study led by a University of Cincinnati researcher provides more clarity on how immunotherapy treatment for patients with cancer affects COVID-19 severity. Health News | Study Investigates How Immunotherapy Affects COVID-19 Outcomes.

Health News | Adult Cancer Survivors at Higher Risk of Bone Fractures: Research - Vimarsana News

Health News | Adult Cancer Survivors at Higher Risk of Bone Fractures: Research

Get latest articles and stories on Health at LatestLY. Adult cancer survivors, particularly those diagnosed within five years and/or have a history of chemotherapy, have an increased risk for bone fractures, specifically pelvic and vertebral fractures, compared to older adults without cancer, according to a new large study by researchers at the American Cancer Society (ACS). Health News | Adult Cancer Survivors at Higher Risk of Bone Fractures: Research.